- Polymicrobial nature of chronic diabetic foot ulcer biofilm infections
- Costs of diabetic foot complications
- Comparison between honey and povidone iodine for diabetic foot ulcers
- The pro-inflammatory environment in recalcitrant diabetic foot wounds
- Growth factor therapy and HBO as compared to standard wound care
- An Evidence-Based Model Comparing the Cost-effectiveness of Platelet-Rich Plasma Gel to Alternative Therapies for Patients with Nonhealing Diabetic Foot Ulcers
- Is the foot elevation the optimal position for wound healing of a diabetic foot?
- The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration
- Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice
- Pilot trial of biovance collagen-based wound covering for diabetic ulcers
- Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer
- The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers
- Efficacy and Safety of Fresh Fibroblast Allografts in the Treatment of Diabetic Foot Ulcers